These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 5108271

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Oxygen uptake and carbon dioxide release by the human heart under the influence of iproveratril (Verapamil)].
    Rudolph W, Meister W, Kriener J.
    Arzneimittelforschung; 1971 Apr; 21(4):458-62. PubMed ID: 5108140
    [No Abstract] [Full Text] [Related]

  • 3. [Substrate metabolism of the human heart under the influence of iproveratril (Verapamil)].
    Rudolph W, Meister W, Kriener J.
    Arzneimittelforschung; 1971 Apr; 21(4):449-58. PubMed ID: 5108139
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The effects of various coronary dilators on oxygen consumption, heart frequency and blood pressure in a standardized charge on the ergometer].
    Roskamm H, Fröhlich GJ, Reindell H.
    Arzneimittelforschung; 1966 Jul; 16(7):835-41. PubMed ID: 4967662
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of iproveratril and nitroglycerin in the heart and coronary circulation of dogs.
    Ross G, Jorgensen C.
    Am Heart J; 1968 Jul; 76(1):74-8. PubMed ID: 4968958
    [No Abstract] [Full Text] [Related]

  • 11. [Coronary blood flow and oxygen consumption of human heart under the effect of hexobendine].
    Rudolph W, Marko I, Baubkus H, Müller-Seydlitz P, Gadomski M, Posse P, Gulde M, Jetschgo G.
    Arzneimittelforschung; 1970 May; 20(5):637-47. PubMed ID: 5468053
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Control of myocardial metabolism by verapamil. Sites of action and therapeutic effects].
    Fleckenstein A.
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1317+. PubMed ID: 5536556
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of verapamil on coronary blood flow, oxygen utilisation and carbon dioxide production in human heart].
    Rudolph W, Kriener J, Meister W.
    Klin Wochenschr; 1971 Sep 01; 49(17):982-8. PubMed ID: 5093463
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Limitation of the disappearance of energy-rich phosphate compounds in the hyperactive atrial and ventricular myocardium by divalent Ca-antagonistic inhibitors of electromechanical coupling (iprovdratril, D 600, prenylamine)].
    Doring HJ, Leder O, Jaedicke W, Reindell A, Fleckenstein A.
    Pflugers Arch; 1969 Sep 01; 312(1):R7-8. PubMed ID: 5390299
    [No Abstract] [Full Text] [Related]

  • 19. The actions of verapamil on experimental arrhythmias.
    Rodrigues-Pereira E, Viana AP.
    Arzneimittelforschung; 1968 Feb 01; 18(2):175-9. PubMed ID: 5695375
    [No Abstract] [Full Text] [Related]

  • 20. [On the influence of beta-receptor blocking agents, iproveratril, quinidine and reserpine on the effect of k-strophanthin in the guinea pig heart].
    Fratz R, Greeff K, Wagner J.
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967 Feb 01; 256(2):196-206. PubMed ID: 4233000
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.